
News|Articles|September 1, 2008
FDA Pipeline preview, September 2008
Recent FDA action (through September 2008) related to Immediate-release diclofenac capsules, tocilizumab, sugammadex, topical alprostadil cream, fospropofol, iloperidone, lacosamide, and vascular endothelial growth factor b.
Advertisement
Approvable designations
Recommended for approval
Nonapprovable designations
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access
2
Centanafadine hits primary and key secondary endpoints in ADHD phase 3b trial
3
Brukinsa/rituximab cuts progression risk 43% in mantle cell lymphoma
4
New study confirms benefits of GLP-1 drugs in patients with PAD
5
































